← Eichor
Study identifier: NCT01238250 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

Condition: 16P11.2 Deletion Syndrome · 16p11.2 Duplications · 1Q21.1 Deletion  ·  Sponsor: Simons Searchlight

PhaseN/A
Planned participants100000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders and may be associated with autism. Simons Searchlight collects medical, behavioral, learning, and developmental information from people who have these rare genetic changes. The goal of this study is to improve the clinical care and treatment for these people. Simons Searchlight partners with families to collect data and distribute it to qualified researchers.

This description comes directly from the study's public registry record.

Talk to the study team

Simons Searchlight Study Coordinator  ·  855-329-5638  ·  coordinator@SimonsSearchlight.org

Always discuss trial participation with your own doctor first.

Locations (2)

Boston Children's HospitalBoston, Massachusetts, United StatesRecruiting
Geisinger Health SystemLewisburg, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01238250